Precision recruitment for high-risk participants in a COVID-19 cohort study

ABSTRACT: Studies for developing diagnostics and treatments for infectious diseases usually require observing the onset of infection during the study period. However, when the infection base rate incidence is low, the cohort size required to measure an effect becomes large, and recruitment becomes costly and prolonged. We describe an approach for reducing recruiting time and resources in a COVID-19 study by targeting recruitment to high-risk individuals. Our approach is based on direct and longitudinal connection with research participants and computes individual risk scores from individually permissioned data about socioeconomic and behavioural data, in combination with predicted local prevalence data. When we used these scores to recruit a balanced cohort of participants for a COVID-19 detection study, we obtained a 4- to 7-fold greater COVID-19 infection incidence compared with similar real-world study cohorts.

Read the full publication here.

Related work

Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research

January 8, 2026

Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals

December 16, 2025

Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer

December 2, 2025

Have questions?

CONTACT US

Good reads

Patient Data Access News
Digital Divide Goes Beyond Broadband, Rests with Digital Health Literacy

Stat
Paying Research Participants — A Lot — May Be a Key to Increasing Diversity in Studies

Outsourcing Pharma
Bioethics International Reveals Index to Score Pharma on Trial Diversity

PatientEngagementHIT
$35 Cap on Insulin Could Boost Medication Adherence, Satisfaction

Healthcare Dive
How Technology Will Shape Healthcare in 2023

What we’ve been up to

Patient Data Access News
Using Real RWD to Better Understand and Engage Neuro Patients

Evidation
Predictors of Seeking Care for Influenza-Like Illness in a Novel Digital Study

Builin
Evidation is a 2023 Best Place to Work!

Upcoming events

Thanks to everyone who took the time to meet with us in San Francisco at this year’s J.P. Morgan Annual Conference and its surrounding events. Our team looks forward to staying in touch and helping you produce better health outcomes in 2023!